https://vettapharma.com/pharmaceutical-news/sleep-2026-jazz-pharmaceuticals-to-showcase-21-xywav-abstracts/ 2026-06-05T08:40:09Z VETTAPHARMA en SLEEP 2026: Jazz Pharmaceuticals to Showcase 21 Xywav Abstracts 2026-06-05T08:38:45Z Blog https://vettapharma.com/pharmaceutical-news/glenmark-launches-generic-lacosamide-injection-in-u-s-market/ 2026-06-05T08:02:04Z VETTAPHARMA en Glenmark Launches Generic Lacosamide Injection in U.S. Market 2026-06-05T08:02:00Z Blog https://vettapharma.com/pharmaceutical-news/takeda-records-jpy-402-5-billion-legal-provision-after-amitiza-verdict/ 2026-06-05T07:09:26Z VETTAPHARMA en Takeda Records JPY 402.5 Billion Legal Provision After AMITIZA Verdict 2026-06-05T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/eular-2026-data-highlight-ucbs-cimzia-consistency-across-rf-levels-in-ra/ 2026-06-05T07:23:09Z VETTAPHARMA en EULAR 2026 Data Highlight UCB’s CIMZIA Consistency Across RF Levels in RA 2026-06-05T08:00:00Z Blog